Fundraising Fox

Biotech Series A Investors & VC Firms

1537 firms in this list, with a median first check of $500K. 317 of them lead rounds. Generated from verified public data and updated continuously.

Creative Destruction Lab (CDL)
TorontoPre-Seed–Series A$50K – $250K
3 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
72 people
Lux Capital
New YorkPre-Seed–Growth$100K – $100M
48 people
Aju IB Invesment Corporation
SeoulSeed–Late Stage
Rockstart
AmsterdamPre-Seed–Series B$114.4K – $2.3M
29 people
Foresite Capital
LarkspurPre-Seed–Late Stage
59 people
Octopus Ventures
LondonPre-Seed–Late Stage$130K – $1.3M
87 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
48 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
71 people
IDEA NC
DurhamSeed–Late Stage$250K – $2M
2 people
Speedinvest
ViennaPre-Seed–Late Stage$5M – $30M
81 people
Oxford Science Enterprises
OxfordPre-Seed–Growth$63.5K – $31.8M
78 people
Bantam Group
WestwoodPre-Seed–Series A
1 person
Paladin Capital Group
WashingtonSeed–Late Stage$100K – $5M
73 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
49 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
75 people
Portfolia
San MateoSeed–Late Stage
58 people
RA Capital
BostonSeed–Late Stage
29 people
ARCH Venture Partners
ChicagoSeed–Growth$50K – $250M
43 people
AlleyCorp
New YorkPre-Seed–Series A$1M – $5M
37 people
IMM Investment Japan
SeoulSeed–Late Stage
21 people
Pillar VC
BostonPre-Seed–Series B$50K – $4M
62 people
Gobi Partners
Hong KongPre-Seed–Late Stage$709K – $37M
74 people
Future Planet Capital
LondonSeed–Late Stage
34 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.